Bioter S.A. (BIOT) - Total Assets
Based on the latest financial reports, Bioter S.A. (BIOT) holds total assets worth €85.09 Million EUR (≈ $99.48 Million USD) as of December 2022. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how efficiently does Bioter S.A. generate cash for how efficiently the company converts equity into cash flow.
Bioter S.A. - Total Assets Trend (2014–2022)
This chart illustrates how Bioter S.A.'s total assets have evolved over time, based on quarterly financial data. See current stock price of Bioter S.A. for real-time trading data and today's change.
Bioter S.A. - Asset Composition Analysis
Current Asset Composition (December 2022)
Bioter S.A.'s total assets of €85.09 Million consist of 32.1% current assets and 67.9% non-current assets. Explore how liquid is Bioter S.A.'s working capital to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €728.00K | 0.0% |
| Accounts Receivable | €26.58 Million | 31.2% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €3.80 Million | 4.5% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2014–2022)
This chart illustrates how Bioter S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bioter S.A.'s current assets represent 32.1% of total assets in 2022, a decrease from 34.5% in 2014.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2022, down from 0.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 31.2% of total assets.
Bioter S.A. Competitors by Total Assets
Key competitors of Bioter S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
WSP Global Inc
TO:WSP
|
Canada | CA$19.34 Billion |
|
Samsung Engineering
KO:028050
|
Korea | ₩10.04 Trillion |
|
Shanghai Tunnel Engineering Co Ltd
SHG:600820
|
China | CN¥184.69 Billion |
|
Kepco Plant S&
KO:051600
|
Korea | ₩1.65 Trillion |
|
Shanghai Tongji Science&Technology Industrial Co Ltd
SHG:600846
|
China | CN¥12.86 Billion |
|
Shanghai Urban Architecture Design Co. Ltd.
SHE:300983
|
China | CN¥2.83 Billion |
|
Shanghai Geoharbour Construction Group Co Ltd
SHG:605598
|
China | CN¥2.31 Billion |
|
SGC Energy Co Ltd
KO:005090
|
Korea | ₩3.37 Trillion |
Bioter S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.13 | 0.15 | 0.18 |
| Quick Ratio | 0.13 | 0.15 | 0.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-165.43 Million | €-154.19 Million | €-138.52 Million |
Bioter S.A. - Advanced Valuation Insights
This section examines the relationship between Bioter S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 0.4% |
| Total Assets | €85.09 Million |
| Market Capitalization | $3.45 Million USD |
Valuation Analysis
Below Book Valuation: The market values Bioter S.A.'s assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Bioter S.A.'s assets grew by 0.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Bioter S.A. (2014–2022)
The table below shows the annual total assets of Bioter S.A. from 2014 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | €85.09 Million ≈ $99.48 Million |
+0.40% |
| 2021-12-31 | €84.75 Million ≈ $99.08 Million |
-1.73% |
| 2020-12-31 | €86.24 Million ≈ $100.82 Million |
-2.17% |
| 2019-12-31 | €88.15 Million ≈ $103.06 Million |
+1.61% |
| 2018-12-31 | €86.75 Million ≈ $101.42 Million |
-3.44% |
| 2017-12-31 | €89.84 Million ≈ $105.04 Million |
-1.16% |
| 2016-12-31 | €90.90 Million ≈ $106.27 Million |
-8.85% |
| 2015-12-31 | €99.73 Million ≈ $116.59 Million |
-16.17% |
| 2014-12-31 | €118.96 Million ≈ $139.07 Million |
-- |
About Bioter S.A.
Bioter S.A. operates as a technical construction company in Greece and internationally. The company is involved in the execution of various projects, such as roads, ports, industrial-energy, electromechanical-communications, airports, war industries factories, etc., as well as private projects, such as offices, banks, bus stations, etc. The company was founded in 1961 and is based in Athens, Gree… Read more